Categories Analysis, Consumer, LATEST

Tapestry (TPR) looks set for another strong year amid buoyant demand

In the most recent quarter, digital sales jumped more than 50% versus the prior year, reflecting the efforts to boost e-commerce

The ongoing economic recovery amid market reopening and improving labor market conditions has lifted consumer confidence and people are once again spending on discretionary items. The pandemic-relief package and vaccination drive are also contributing to the demand recovery.

Shock-proof Biz

Tapestry, Inc. (NYSE: TPR), a leading fashion and lifestyle brands company, registered strong sales growth this year, to the extent that the latest quarterly numbers even surpassed the pre-pandemic levels. Having tackled supply chain issues effectively ahead of the holiday season, the company looks to strengthen the business further in fiscal 2022.

Read management/analysts’ comments on Tapestry’s Q1 2022 earnings

The New York-based firm, which owns high-end handbag brand Coach New York, adopted prompt measures to ramp up its eCommerce capabilities after being hit by the pandemic. The other leading business divisions are luxury apparel and accessory brands Stuart Weitzman and Kate Spade-New York. The share of digital sales increased steadily even as the customer base continued to expand.

Tapestry’s stock rebounded this month after several weeks of lackluster performance and stayed above its 52-week average. TPR is favorably undervalued and there is ample room for growth. With market watchers predicting a double-digit growth over the next twelve months, the stock is worth keeping on the watch-list, especially in the current inflationary environment.

From Tapestry’s first quarter 2022 earnings conference call:

“Coach continues to stand out even amid external pressures. Customers are engaging with the brand at an increasing rate given the traction of our product and marketing. We’re driving continued momentum as we enter the important holiday quarter. The brand has proven that the foundational changes we’ve made are working and our results are sustainable. We are increasingly confident in our ability to drive both revenue and profit gains for fiscal ’22 and beyond.”

Acceleration Program

The company is probably leveraging the success of its Acceleration Program, with focus on streamlining the business and enhancing the digital channels with the support of data and analytics. The data-driven model helps in developing targeted products and achieving marketing and pricing efficiency.

It is worth noting that eCommerce sales grew about 50% in the latest quarter, aided by continued strength in North America and China. SG&A expenses, as a percentage of sales, were almost flat year-over-year. A cut-down in promotional activities is also having a positive effect on margins.

Key quarterly highlights from Nike’s Q1 financial results

Profitability improved and the numbers topped expectations in recent quarters as the company shrugged off the COVID-induced headwinds, which had dragged the bottom-line into negative territory last year. In the September quarter, Net income was almost flat at $227 million but exceeded analysts’ estimates. Net sales increased 26% to $1.48 billion and topped experts’ projections. Taking a cue from the positive outcome, Tapestry executives raised their full-year guidance.

Stock Performance

After dipping to multi-year lows in the first half of 2020, TPR bounced back towards the end of the year and maintained the uptrend since then. In the past twelve months, its value nearly doubled. The stock traded slightly lower early Monday, after closing the previous session at $45.53.

Most Popular

HP Inc. (HPQ) stock research summary | Q3 2021

HP Inc has shown a strong performance in Q4 2021. In spite of remote working, HP has shown a strong demand for PC and printer. The company has beat Zacks

VMware Inc. (VMW) stock research summary | Q3 2021

In this era of digital transformation, the technology industry is seeing a rapid influx of innovative products and solutions that help businesses adapt to the fast-changing and complex environment. VMware

IPO Alert: Cancer drug company Nuvectis Pharma set for $30-million IPO

After months of hectic activity, the IPO market experienced a lull in the Thanksgiving week, but it is still headed for a record year though the rush led by the

Add Comment
Viewing Highlight